Objective To investigate the effects of calprotectin(S100A8/A9)on the biological activity of acute myeloid leukemia(AML)cells harboring a DNA methyltransferase 3A(DNMT3A)mutation and to explore the underlying molecula...Objective To investigate the effects of calprotectin(S100A8/A9)on the biological activity of acute myeloid leukemia(AML)cells harboring a DNA methyltransferase 3A(DNMT3A)mutation and to explore the underlying molecular mechanisms involved.Methods AML monoclonal cell lines harboring the DNMT3A^(R882H) mutation were generated via lentiviral transduction and limiting dilution.RNA sequencing was used for differential gene expression analysis,followed by bioinformatic pathway enrichment and gene correlation analyses.The biological effects of paquinimod,a selective S100A8/A9 inhibitor,on DNMT3A^(R882H) AML cells were assessed via Cell Counting Kit(CCK-8)proliferation assays,Annexin V/PI staining,cell cycle analysis,cell adhesion assays,and transwell migration assays.Results Differential gene expression analysis revealed 442 upregulated and 535 downregulated genes in DNMT3A-mutated(DNMT3A^(mut))cells compared with those in DNMT3A wild-type(DNMT3A^(wt))cells,with the S100A8/A9 complex recurrently enriched in Reactome pathway analysis.Compared with healthy controls,patients with AML presented increased expression of S100A8 and S100A9 and increased expression of DNMT3A^(mut) cells relative to DNMT3A^(wt) cells,which was correlated with poor prognosis in patients with AML.There were no notable differences in proliferation among the DNMT3A^(mut),DNMT3A^(wt),and empty vector cells under normal or starvation conditions.However,paquinimod treatment notably inhibited the proliferation,migration,and adhesion of DNMT3A^(mut) AML cells in a dose-dependent manner,causing G0/G1 cell cycle arrest,whereas no significant effects on apoptosis were observed.Paquinimod also downregulated key adhesion molecules,including intercellular adhesion molecule 1(ICAM-1),vascular cell adhesion molecule 1(VCAM-1),monocyte chemoattractant protein-1(MCP-1),and matrix metalloproteinase-2(MMP-2).Additionally,S100A8 and S100A9 expression was upregulated in a dose-dependent manner in response to cytarabine treatment.Conclusion Elevated S100A8/A9 expression contributes to the abnormal proliferation,migration,adhesion,and chemoresistance of DNMT3A^(mut) AML cells.Targeting S100A8/A9 alone or in combination with other treatments represents a promising therapeutic strategy for DNMT3A^(mut) AML.展开更多
钙结合蛋白S100A(calcium binding protein S100A,S100A)4是经RNA互作组技术发现的一种新型RNA结合蛋白(RNA-binding proteins,RBPs)[1],能够识别特定RNA结合域并与RNA相互作用,在转录后基因表达调控中起着重要作用[2]。先前的研究发现,...钙结合蛋白S100A(calcium binding protein S100A,S100A)4是经RNA互作组技术发现的一种新型RNA结合蛋白(RNA-binding proteins,RBPs)[1],能够识别特定RNA结合域并与RNA相互作用,在转录后基因表达调控中起着重要作用[2]。先前的研究发现,S100A4不仅在银屑病患者皮肤的真皮组织中表达上调,而且能通过影响表皮细胞增殖和真皮血管增生参与银屑病的发生发展,然而其中潜在的调控机制尚不清楚[3]。展开更多
基金funded by the National Natural Science Foundation of China(Grant No.82270177)the China Medicine Education Association 2024 Medical Science and Technology Research Project(Grant No.2024KTZ035).
文摘Objective To investigate the effects of calprotectin(S100A8/A9)on the biological activity of acute myeloid leukemia(AML)cells harboring a DNA methyltransferase 3A(DNMT3A)mutation and to explore the underlying molecular mechanisms involved.Methods AML monoclonal cell lines harboring the DNMT3A^(R882H) mutation were generated via lentiviral transduction and limiting dilution.RNA sequencing was used for differential gene expression analysis,followed by bioinformatic pathway enrichment and gene correlation analyses.The biological effects of paquinimod,a selective S100A8/A9 inhibitor,on DNMT3A^(R882H) AML cells were assessed via Cell Counting Kit(CCK-8)proliferation assays,Annexin V/PI staining,cell cycle analysis,cell adhesion assays,and transwell migration assays.Results Differential gene expression analysis revealed 442 upregulated and 535 downregulated genes in DNMT3A-mutated(DNMT3A^(mut))cells compared with those in DNMT3A wild-type(DNMT3A^(wt))cells,with the S100A8/A9 complex recurrently enriched in Reactome pathway analysis.Compared with healthy controls,patients with AML presented increased expression of S100A8 and S100A9 and increased expression of DNMT3A^(mut) cells relative to DNMT3A^(wt) cells,which was correlated with poor prognosis in patients with AML.There were no notable differences in proliferation among the DNMT3A^(mut),DNMT3A^(wt),and empty vector cells under normal or starvation conditions.However,paquinimod treatment notably inhibited the proliferation,migration,and adhesion of DNMT3A^(mut) AML cells in a dose-dependent manner,causing G0/G1 cell cycle arrest,whereas no significant effects on apoptosis were observed.Paquinimod also downregulated key adhesion molecules,including intercellular adhesion molecule 1(ICAM-1),vascular cell adhesion molecule 1(VCAM-1),monocyte chemoattractant protein-1(MCP-1),and matrix metalloproteinase-2(MMP-2).Additionally,S100A8 and S100A9 expression was upregulated in a dose-dependent manner in response to cytarabine treatment.Conclusion Elevated S100A8/A9 expression contributes to the abnormal proliferation,migration,adhesion,and chemoresistance of DNMT3A^(mut) AML cells.Targeting S100A8/A9 alone or in combination with other treatments represents a promising therapeutic strategy for DNMT3A^(mut) AML.
文摘钙结合蛋白S100A(calcium binding protein S100A,S100A)4是经RNA互作组技术发现的一种新型RNA结合蛋白(RNA-binding proteins,RBPs)[1],能够识别特定RNA结合域并与RNA相互作用,在转录后基因表达调控中起着重要作用[2]。先前的研究发现,S100A4不仅在银屑病患者皮肤的真皮组织中表达上调,而且能通过影响表皮细胞增殖和真皮血管增生参与银屑病的发生发展,然而其中潜在的调控机制尚不清楚[3]。
